Brent M. Booker
- Pharmacology top 10%
- Pharmacology top 10%
- Molecular Medicine top 5%
- Infectious Diseases
- Epidemiology
- Co-authors
- Patrick F. SmithJulie BullockCurtis E. HaasWilliam J. JuskoCharles S. BerensonAlan ForrestCharles H. BallowSujata M. Bhavnani
- Topics
- Antibiotics Pharmacokinetics and Efficacy (7 papers)Bacterial Identification and Susceptibility Testing (3 papers)Pneumonia and Respiratory Infections (3 papers)
- Partner nations
- United StatesNew ZealandCanada
In The Last Decade
Brent M. Booker
15 papers receiving 356 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 116
- Pharmacology 79
- Molecular Medicine 78
- Infectious Diseases 74
- Epidemiology 66
Countries citing papers authored by Brent M. Booker
This map shows the geographic impact of Brent M. Booker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent M. Booker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent M. Booker more than expected).
Fields of papers citing papers by Brent M. Booker
This network shows the impact of papers produced by Brent M. Booker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent M. Booker. The network helps show where Brent M. Booker may publish in the future.
Co-authorship network of co-authors of Brent M. Booker
This figure shows the co-authorship network connecting the top 25 collaborators of Brent M. Booker. A scholar is included among the top collaborators of Brent M. Booker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent M. Booker. Brent M. Booker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 7 | |
| 3 | 21 | |
| 4 | 29 | |
| 5 | 1 | |
| 6 | 37 | |
| 7 | 95 | |
| 8 | 16 | |
| 9 | In Vitro Antagonism with the Combination of Vancomycin and Clindamycin Against Staphylococcus aureus | 7 |
| 10 | 32 | |
| 11 | 10 | |
| 12 | 1 | |
| 13 | 19 | |
| 14 | 59 | |
| 15 | 20 |
About Brent M. Booker
Brent M. Booker is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Pharmacology, having authored 15 papers that have together received 372 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (78 citations), Pharmacology (79 citations) and Applied Microbiology and Biotechnology (16 citations). Brent M. Booker has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include Patrick F. Smith, Julie Bullock, Curtis E. Haas, William J. Jusko, Charles S. Berenson, Alan Forrest, Charles H. Ballow, Sujata M. Bhavnani, Paul G. Ambrose and Abayomi Ogundele. Their work appears in journals such as Blood, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.